Outpatient Addiction Recovery Services
2360 Hospital Drive, Lower Level, Aliquippa, PA 15001
Outpatient Addiction Recovery Services is an outpatient facility in Aliquippa, PA offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicaid, Medicare, and private insurance.
Licenses and accreditations
- Drug Enforcement Agency (DEA)Registered with the Drug Enforcement Administration.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Outpatient
- Regular appointments while living at home.
- Outpatient methadone/buprenorphine or naltrexone treatment
- Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Accepts clients using MAT but prescribed elsewhere
- Accepts clients whose medication for opioid use is prescribed elsewhere.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
- Relapse prevention with naltrexone
- Naltrexone to help prevent relapse.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Medicaid; Medicare; Private health insurance.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
More details this facility reports
- External Opioid Medications Source
- No formal relationship with prescribing entity.
- Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity.
- Pharmacotherapies
- Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement.
- Treatment Approaches
- Telemedicine/telehealth therapy.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Complete medical history/physical exam; Comprehensive substance use assessment; Screening for substance use; Screening for tobacco use.
- Testing
- Drug and alcohol oral fluid testing; Drug or alcohol urine screening.
- Transitional Services
- Naloxone and overdose education.
- Education and Counseling Services
- Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.